Enveric Biosciences Inc. is a biotechnology company primarily focused on developing novel small-molecule therapeutics for the treatment of cancer and neurological diseases. By leveraging advanced technologies, the company aims to address unmet medical needs through innovative pharmaceutical approaches. Enveric Biosciences engages in preclinical research that incorporates cutting-edge techniques in medicinal science, focusing particularly on indications with high demand for new therapeutic options. The company's portfolio includes both proprietary and partnered drug candidates, advancing through various stages of clinical development. As part of the healthcare sector, Enveric Biosciences plays a crucial role in the broader effort to discover and develop new treatments that can significantly improve patient outcomes. Though in early stages of development, the company’s potential contributions to biotech innovation underscore its role in driving forward progress in medical research and drug discovery within the financial markets. Based in North America, Enveric pursues collaborations with various research institutions and biotech companies to enhance its drug development processes.